{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:36:02Z","timestamp":1792290962211,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11894-025-00994-4","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T02:12:12Z","timestamp":1749867132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Managing Pouchitis: Where do Antibiotics End, and Advanced Therapies Begin?"],"prefix":"10.1007","volume":"27","author":[{"given":"Arpita","family":"Jajoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrad","family":"Hakimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Syal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"7","key":"994_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/ecco-jcc\/jjy040","volume":"12","author":"L Parragi","year":"2018","unstructured":"Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, et al. Colectomy rates in ulcerative colitis are low and decreasing: 10-year Follow-up data from the Swiss IBD cohort study. J Crohns Colitis. 2018;12(7):811\u20138.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"994_CR2","first-page":"1225","volume":"26","author":"EL Barnes","year":"2020","unstructured":"Barnes EL, Jiang Y, Kappelman MD, Long MD, Sandler RS, Kinlaw AC, et al. Decreasing colectomy rate for ulcerative colitis in the united States between 2007 and 2016: A time trend analysis. Inflamm Bowel Dis. 2020;26(8):1225\u201331.","journal-title":"Inflamm Bowel Dis"},{"key":"994_CR3","doi-asserted-by":"crossref","unstructured":"Baek JE, Park JB, Bae JH, Kim MH, Hong SW, Hwang SW et al. Incidence, risk factors, and outcomes of chronic Antibiotic-Refractory pouchitis in Korean patients with ulcerative colitis. Gut Liver. 2024.","DOI":"10.5009\/gnl240226"},{"issue":"8","key":"994_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.cgh.2020.06.035","volume":"19","author":"EL Barnes","year":"2021","unstructured":"Barnes EL, Herfarth HH, Kappelman MD, Zhang X, Lightner A, Long MD, et al. Incidence, risk factors, and outcomes of pouchitis and Pouch-Related complications in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2021;19(8):1583\u2013e914.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"994_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/MIB.0000000000001061","volume":"23","author":"AL Lightner","year":"2017","unstructured":"Lightner AL, Mathis KL, Dozois EJ, Hahnsloser D, Loftus EV, Raffals LE, et al. Results at up to 30 years after ileal Pouch-Anal anastomosis for chronic ulcerative colitis. Inflamm Bowel Dis. 2017;23(5):781\u201390.","journal-title":"Inflamm Bowel Dis"},{"key":"994_CR6","doi-asserted-by":"crossref","unstructured":"Barnes EL, Allin KH, Iversen AT, Herfarth HH, Jess T. Increasing incidence of pouchitis between 1996 and 2018: A Population-Based Danish cohort study. Clinical Gastroenterology and Hepatology; 2022.","DOI":"10.1016\/j.cgh.2022.04.015"},{"issue":"7","key":"994_CR7","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/MIB.0000000000001119","volume":"23","author":"EL Barnes","year":"2017","unstructured":"Barnes EL, Herfarth HH, Sandler RS, Chen W, Jaeger E, Nguyen VM, et al. Pouch-Related symptoms and quality of life in patients with ileal Pouch-Anal anastomosis. Inflamm Bowel Dis. 2017;23(7):1218\u201324.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"994_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/SLA.0b013e31827d99a2","volume":"257","author":"VW Fazio","year":"2013","unstructured":"Fazio VW, Kiran RP, Remzi FH, Coffey JC, Heneghan HM, Kirat HT, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg. 2013;257(4):679\u201385.","journal-title":"Ann Surg"},{"key":"994_CR9","doi-asserted-by":"crossref","unstructured":"Barnes EL, Kochar B, Jessup HR, Herfarth HH. The Incidence and Definition of Crohn\u2019s Disease of the Pouch: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2019.","DOI":"10.1093\/ibd\/izz005"},{"key":"994_CR10","doi-asserted-by":"crossref","unstructured":"Barnes EL, Kappelman MD, Zhang X, Long MD, Sandler RS, Herfarth HH. Patients with pouchitis demonstrate a significant cost burden in the first two years after ileal Pouch-Anal anastomosis. Clin Gastroenterol Hepatol; 2021.","DOI":"10.14309\/01.ajg.0000777080.42167.a7"},{"issue":"3","key":"994_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/ecco-jcc\/jjw157","volume":"11","author":"N Maharshak","year":"2017","unstructured":"Maharshak N, Cohen NA, Reshef L, Tulchinsky H, Gophna U, Dotan I. Alterations of enteric microbiota in patients with a normal ileal pouch are predictive of pouchitis. J Crohns Colitis. 2017;11(3):314\u201320.","journal-title":"J Crohns Colitis"},{"issue":"9","key":"994_CR12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/codi.14651","volume":"21","author":"XH Gao","year":"2019","unstructured":"Gao XH, Li JQ, Khan F, Chouhan H, Yu GY, Remer E, et al. Difference in the frequency of pouchitis between ulcerative colitis and Familial adenomatous polyposis: is the explanation in Peripouch fat? Colorectal Dis. 2019;21(9):1032\u201344.","journal-title":"Colorectal Dis"},{"issue":"4","key":"994_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1053\/gast.2001.28017","volume":"121","author":"MJ Carter","year":"2001","unstructured":"Carter MJ, Di Giovine FS, Cox A, Goodfellow P, Jones S, Shorthouse AJ, et al. The Interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology. 2001;121(4):805\u201311.","journal-title":"Gastroenterology"},{"issue":"11","key":"994_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/DCR.0b013e3181f22635","volume":"53","author":"R Sehgal","year":"2010","unstructured":"Sehgal R, Berg A, Hegarty JP, Kelly AA, Lin Z, Poritz LS, et al. NOD2\/CARD15 mutations correlate with severe pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum. 2010;53(11):1487\u201394.","journal-title":"Dis Colon Rectum"},{"issue":"46","key":"994_CR15","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.3748\/wjg.v11.i46.7323","volume":"11","author":"KM Lammers","year":"2005","unstructured":"Lammers KM, Ouburg S, Morr\u00e9 SA, Crusius JB, Gionchett P, Rizzello F, et al. Combined carriership of TLR9-1237\u00a0C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol. 2005;11(46):7323\u20139.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"994_CR16","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(20)32478-1","volume":"158","author":"G Syal","year":"2020","unstructured":"Syal G, Li D, Bonthala N, Vasiliauskas E, Feldman EJ, Ha C, et al. Serological and genetic markers are associated with ileal pouch outcomes after ileal pouch anal anastomosis. Gastroenterology. 2020;158(6):S\u2013717.","journal-title":"Gastroenterology"},{"key":"994_CR17","doi-asserted-by":"crossref","unstructured":"Gabbiadini R, Dal Buono A, Correale C, Spinelli A, Repici A, Armuzzi A et al. Ileal Pouch-Anal anastomosis and pouchitis: the role of the microbiota in the pathogenesis and therapy. Nutrients. 2022;14(13).","DOI":"10.3390\/nu14132610"},{"issue":"3","key":"994_CR18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1053\/j.gastro.2015.05.041","volume":"149","author":"L Reshef","year":"2015","unstructured":"Reshef L, Kovacs A, Ofer A, Yahav L, Maharshak N, Keren N, et al. Pouch inflammation is associated with a decrease in specific bacterial taxa. Gastroenterology. 2015;149(3):718\u201327.","journal-title":"Gastroenterology"},{"issue":"4","key":"994_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, et al. Dysbiosis-Induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27(4):659\u2013e705.","journal-title":"Cell Host Microbe"},{"issue":"7","key":"994_CR20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/ibd\/izad288","volume":"30","author":"P Santiago","year":"2024","unstructured":"Santiago P, Quinn KP, Chen J, Friton JJ, Rypstra CR, Kashyap PC, et al. Altered bile acid and pouch microbiota composition in patients with chronic pouchitis. Inflamm Bowel Dis. 2024;30(7):1062\u201370.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"994_CR21","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/BF02285195","volume":"40","author":"WJ Sandborn","year":"1995","unstructured":"Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Rossi SS, Hofmann AF, et al. Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci. 1995;40(7):1474\u201383.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"994_CR22","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.gastro.2024.05.021","volume":"167","author":"M Camilleri","year":"2024","unstructured":"Camilleri M, Pouchitis. Is it time to think beyond the inflammation in the pouch?? Gastroenterology. 2024;167(5):821\u20135.","journal-title":"Gastroenterology"},{"issue":"8","key":"994_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/apt.13780","volume":"44","author":"KM Schieffer","year":"2016","unstructured":"Schieffer KM, Williams ED, Yochum GS, Koltun WA. Review article: the pathogenesis of pouchitis. Aliment Pharmacol Ther. 2016;44(8):817\u201335.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"994_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.gastro.2023.10.015","volume":"166","author":"EL Barnes","year":"2024","unstructured":"Barnes EL, Agrawal M, Syal G, Ananthakrishnan AN, Cohen BL, Haydek JP, et al. AGA clinical practice guideline on the management of pouchitis and inflammatory pouch disorders. Gastroenterology. 2024;166(1):59\u201385.","journal-title":"Gastroenterology"},{"issue":"5","key":"994_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archsurg.1996.01430170043007","volume":"131","author":"RD Hurst","year":"1996","unstructured":"Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131(5):497\u2013500. discussion 1\u20132.","journal-title":"Arch Surg"},{"issue":"10","key":"994_CR26","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/ibd.20187","volume":"13","author":"KL Isaacs","year":"2007","unstructured":"Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, et al. Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007;13(10):1250\u20135.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"994_CR27","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/ibd\/izac043","volume":"28","author":"G Lupu","year":"2022","unstructured":"Lupu G, Weaver KN, Herfarth HH, Barnes EL. Vancomycin is effective in the treatment of chronic inflammatory conditions of the pouch. Inflamm Bowel Dis. 2022;28(10):1610\u20133.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"994_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/BF02093783","volume":"39","author":"MV Madden","year":"1994","unstructured":"Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci. 1994;39(6):1193\u20136.","journal-title":"Dig Dis Sci"},{"key":"994_CR29","first-page":"964","volume":"47","author":"A Sambuelli","year":"2000","unstructured":"Sambuelli A, Boerr L, Negreira S, Gil A, Carmatino G, Huernos S, et al. Budesonide enemas versus oral metronidazole in pouchitis. A double-blind double-dummy controlled trial. Gut. 2000;47:964. Suppl III A249).","journal-title":"Gut"},{"issue":"4","key":"994_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10350-006-0828-3","volume":"50","author":"B Shen","year":"2007","unstructured":"Shen B, Fazio VW, Remzi FH, Bennett AE, Lopez R, Brzezinski A, et al. Combined Ciprofloxacin and Tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum. 2007;50(4):498\u2013508.","journal-title":"Dis Colon Rectum"},{"issue":"5 Suppl 1","key":"994_CR31","doi-asserted-by":"publisher","first-page":"A453","DOI":"10.1016\/S0016-5085(08)82245-7","volume":"120","author":"B Shen","year":"2001","unstructured":"Shen B, Achkar JP, Lashner BA, Ormsby A, Remzi F, Bevins CL. Ciprofloxacin is more effective in treating acute pouchitis than metronidazole: a randomized clinical trial. Gastroenterology. 2001;120(5 Suppl 1):A453.","journal-title":"Gastroenterology"},{"issue":"6","key":"994_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1365-2036.1999.00553.x","volume":"13","author":"P Gionchetti","year":"1999","unstructured":"Gionchetti P, Rizzello F, Venturi A, Ugolini F, Rossi M, Brigidi P, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther. 1999;13(6):713\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"994_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1463-1318.2004.00746.x","volume":"7","author":"AS Abdelrazeq","year":"2005","unstructured":"Abdelrazeq AS, Kelly SM, Lund JN, Leveson SH. Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis. Colorectal Dis. 2005;7(2):182\u20136.","journal-title":"Colorectal Dis"},{"issue":"5","key":"994_CR34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1046\/j.1365-2036.2002.01203.x","volume":"16","author":"T Mimura","year":"2002","unstructured":"Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, et al. Four-week open-label trial of metronidazole and Ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther. 2002;16(5):909\u201317.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"994_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.14309\/ajg.0000000000003136","volume":"120","author":"G Syal","year":"2025","unstructured":"Syal G, Barnes E, Raffals L, Al Kazzi E, Haydek J, Agarwal M, et al. Medical therapies for prevention and treatment of inflammatory pouch Disorders-A systematic review and Meta-Analysis. Am J Gastroenterol. 2025;120(1):135\u201350.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"994_CR36","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1053\/j.gastro.2019.10.001","volume":"158","author":"V Dubinsky","year":"2020","unstructured":"Dubinsky V, Reshef L, Bar N, Keizer D, Golan N, Rabinowitz K, et al. Predominantly antibiotic-resistant intestinal Microbiome persists in patients with pouchitis who respond to antibiotic therapy. Gastroenterology. 2020;158(3):610\u2013e2413.","journal-title":"Gastroenterology"},{"key":"994_CR37","doi-asserted-by":"crossref","unstructured":"Shore BM, Weaver KN, Allegretti JR, Herfarth HH, Barnes EL. Prevalence of Clostridioides difficile Infection After Ileal Pouch-anal Anastomosis in Patients With Chronic Antibiotic-dependent Pouchitis and Crohn\u2019s-like Disease of the Pouch. Inflamm Bowel Dis. 2022;29.","DOI":"10.1093\/ibd\/izac165"},{"issue":"7","key":"994_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.cgh.2008.02.021","volume":"6","author":"BO Shen","year":"2008","unstructured":"Shen BO, Jiang ZD, Fazio VW, Remzi FH, Rodriguez L, Bennett AE, et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008;6(7):782\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"994_CR39","doi-asserted-by":"crossref","unstructured":"Bar N, Avraham Y, Dubinsky V, Cohen NA, Weiss GA, Banon L et al. Long-term antibiotic treatment in Pouchitis-Patterns of use and safety. Inflamm Bowel Dis. 2021.","DOI":"10.1093\/ibd\/izab209"},{"issue":"11","key":"994_CR40","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.14309\/ajg.0000000000002348","volume":"118","author":"P Santiago","year":"2023","unstructured":"Santiago P, Barnes EL, Raffals LE. Classification and management of disorders of the J pouch. Am J Gastroenterol. 2023;118(11):1931\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"994_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000504750","volume":"37","author":"K Fukushima","year":"2020","unstructured":"Fukushima K, Saito T, Kohyama A, Watanabe K. Increased Quinolone-Resistant mutations of GyrA and parc genes after pouchitis treatment with Ciprofloxacin. Dig Surg. 2020;37(4):321\u201330.","journal-title":"Dig Surg"},{"issue":"5","key":"994_CR42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1365-2036.2010.04401.x","volume":"32","author":"SD McLaughlin","year":"2010","unstructured":"McLaughlin SD, Clark SK, Roberts CH, Perry-Woodford ZL, Tekkis PP, Ciclitira PJ, et al. Extended spectrum beta-lactamase-producing bacteria and Clostridium difficile in patients with pouchitis. Aliment Pharmacol Ther. 2010;32(5):664\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"994_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/gast.2000.9370","volume":"119","author":"P Gionchetti","year":"2000","unstructured":"Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119(2):305\u20139.","journal-title":"Gastroenterology"},{"issue":"1","key":"994_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gut.53.1.108","volume":"53","author":"T Mimura","year":"2004","unstructured":"Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53(1):108\u201314.","journal-title":"Gut"},{"issue":"8","key":"994_CR45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2036.2005.02642.x","volume":"22","author":"B Shen","year":"2005","unstructured":"Shen B, Brzezinski A, Fazio VW, Remzi FH, Achkar JP, Bennett AE, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther. 2005;22(8):721\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Supplement 1","key":"994_CR46","first-page":"A78","volume":"67","author":"J Gulliver","year":"2018","unstructured":"Gulliver J, Lewis S, Douie W. Local experience of vsl#3 use in pouchitis. Gut. 2018;67(Supplement 1):A78.","journal-title":"Gut"},{"issue":"11","key":"994_CR47","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/ecco-jcc\/jjae066","volume":"18","author":"SJ Kousgaard","year":"2024","unstructured":"Kousgaard SJ, Cold F, Halkj\u00e6r SI, Petersen AM, Kjeldsen J, Hansen JM, et al. The effect [micropouch]f Non-pooled multidonor faecal microbiota transplantation for [micropouch]nducing [micropouch]linical [micropouch]emission [micropouch]n patients with [micropouch]hronic pouchitis: [micropouch]esults from a multicentre, [micropouch]andomised, Double-blinded, [micropouch]lacebo-controlled trial [MicroPouch]. J Crohns Colitis. 2024;18(11):1753\u201366.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"994_CR48","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s10620-024-08828-5","volume":"70","author":"JD Claytor","year":"2025","unstructured":"Claytor JD, Lin DL, Magnaye KM, Guerrero YS, Langelier CR, Lynch SV, et al. Effect of fecal microbiota transplant on antibiotic resistance genes among patients with chronic pouchitis. Dig Dis Sci. 2025;70(3):982\u201390.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"994_CR49","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cgh.2017.02.024","volume":"15","author":"KP Quinn","year":"2017","unstructured":"Quinn KP, Tse CS, Lightner AL, Pendegraft RS, Enders FT, Raffals LE. Nonrelaxing pelvic floor dysfunction is an underestimated complication of ileal Pouch-Anal anastomosis. Clin Gastroenterol Hepatol. 2017;15(8):1242\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"13","key":"994_CR50","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2208450","volume":"388","author":"S Travis","year":"2023","unstructured":"Travis S, Silverberg MS, Danese S, Gionchetti P, L\u00f6wenberg M, Jairath V, et al. Vedolizumab for the treatment of chronic pouchitis. N Engl J Med. 2023;388(13):1191\u2013200.","journal-title":"N Engl J Med"},{"issue":"9","key":"994_CR51","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/ibd\/izz030","volume":"25","author":"M Gregory","year":"2019","unstructured":"Gregory M, Weaver KN, Hoversten P, Hicks SB, Patel D, Ciorba MA, et al. Efficacy of Vedolizumab for refractory pouchitis of the Ileo-anal pouch: results from a multicenter US cohort. Inflamm Bowel Dis. 2019;25(9):1569\u201376.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"994_CR52","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/apt.14479","volume":"47","author":"F Bar","year":"2018","unstructured":"Bar F, Kuhbacher T, Dietrich NA, Krause T, Stallmach A, Teich N, et al. Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis. Aliment Pharmacol Ther. 2018;47(5):581\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"994_CR53","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/2050640619871797","volume":"7","author":"B Verstockt","year":"2019","unstructured":"Verstockt B, Claeys C, De Hertogh G, Van Assche G, Wolthuis A, D\u2019Hoore A, et al. Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience. United Eur Gastroenterol J. 2019;7(9):1215\u201325.","journal-title":"United Eur Gastroenterol J"},{"issue":"12","key":"994_CR54","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.cgh.2024.04.030","volume":"22","author":"A Outtier","year":"2024","unstructured":"Outtier A, Louis E, Dewit O, Reenaers C, Schops G, Lenfant M, et al. Efficacy and safety of ustekinumab for chronic pouchitis: A prospective Open-label multicenter study. Clin Gastroenterol Hepatol. 2024;22(12):2468\u2013e741.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"994_CR55","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1007\/s10620-019-05697-1","volume":"64","author":"JE Ollech","year":"2019","unstructured":"Ollech JE, Rubin DT, Glick L, Weisshof R, El Jurdi K, Israel A, et al. Ustekinumab is effective for the treatment of chronic Antibiotic-Refractory pouchitis. Dig Dis Sci. 2019;64(12):3596\u2013601.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"994_CR56","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/00365521.2019.1569718","volume":"54","author":"MD Kjaer","year":"2019","unstructured":"Kjaer MD, Qvist N, Nordgaard-Lassen I, Christensen LA, Kjeldsen J. Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial. Scand J Gastroenterol. 2019;54(2):188\u201393.","journal-title":"Scand J Gastroenterol"},{"key":"994_CR57","doi-asserted-by":"crossref","unstructured":"Syal G, Mishkin DS, Banty A, Lee S, Fontelera N, Hampton M, et al. Effectiveness of oral Tofacitinib in chronic pouchitis: A prospective, Open-Label pilot study. Inflamm Bowel Dis; 2023.","DOI":"10.1093\/ibd\/izad191"},{"key":"994_CR58","doi-asserted-by":"crossref","unstructured":"Khoo E, Amiss A, Ding J, Bryant R. Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. supplement 1 ed. J Crohns Colitis2024. p. i1573.","DOI":"10.1093\/ecco-jcc\/jjad212.0984"},{"key":"994_CR59","doi-asserted-by":"crossref","unstructured":"Robbins L, Zaghiyan K, Melmed G, Vasiliauskas E, Ahmed S, McGovern D et al. Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn\u2019s Disease After Ileal Pouch Anal Anastomosis. J Crohns Colitis. 2016.","DOI":"10.1093\/ecco-jcc\/jjw134"},{"key":"994_CR60","doi-asserted-by":"crossref","unstructured":"Kayal M, Lambin T, Plietz M, Rizvi A, Radcliffe M, Khaitov S, et al. Recycling of precolectomy Anti-Tumor necrosis factor agents in chronic pouch inflammation is associated with treatment failure. Clin Gastroenterol Hepatol; 2020.","DOI":"10.1016\/j.cgh.2020.07.008"},{"issue":"5","key":"994_CR61","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, D\u2019Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570\u201383.","journal-title":"Gastroenterology"},{"issue":"11\u201312","key":"994_CR62","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/apt.15505","volume":"50","author":"M Kayal","year":"2019","unstructured":"Kayal M, Plietz M, Radcliffe M, Rizvi A, Yzet C, Tixier E, et al. Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitis. Aliment Pharmacol Ther. 2019;50(11\u201312):1189\u201394.","journal-title":"Aliment Pharmacol Ther"},{"key":"994_CR63","doi-asserted-by":"crossref","unstructured":"Gupta A, Kizza JF, Ananthakrishnan AN. Histologic activity in an endoscopically normal appearing pouch predicts future risk of pouchitis in patients with ulcerative colitis. Am J Gastroenterol. 2022;16.","DOI":"10.14309\/ajg.0000000000002013"},{"issue":"2","key":"994_CR64","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cgh.2024.06.037","volume":"23","author":"V Jairath","year":"2025","unstructured":"Jairath V, Feagan BG, Silverberg MS, Danese S, Gionchetti P, L\u00f6wenberg M, et al. Mucosal healing with Vedolizumab in patients with chronic pouchitis: EARNEST, a randomized, Double-Blind, Placebo-Controlled trial. Clin Gastroenterol Hepatol. 2025;23(2):321\u2013e303.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"994_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.14309\/ajg.0000000000003055","volume":"120","author":"M Kayal","year":"2025","unstructured":"Kayal M, Posner H, Jimenez D, Huang J, Dubinsky MC, Colombel JF. Endoscopic response reduces the risk of subsequent pouchitis in patients with crohn\u2019s Disease-Like pouch inflammation. Am J Gastroenterol. 2025;120(1):251\u20133.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"994_CR66","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.gie.2018.04.2330","volume":"88","author":"MA Samaan","year":"2018","unstructured":"Samaan MA, Shen B, Mosli MH, Zou G, Sandborn WJ, Shackelton LM, et al. Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. Gastrointest Endosc. 2018;88(2):360\u2013e92.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"994_CR67","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/ibd\/izab124","volume":"28","author":"R Sedano","year":"2022","unstructured":"Sedano R, Nguyen TM, Almradi A, Rieder F, Parker CE, Shackelton LM, et al. Disease activity indices for pouchitis: A systematic review. Inflamm Bowel Dis. 2022;28(4):622\u201338.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"994_CR68","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.cgh.2022.04.026","volume":"21","author":"EL Barnes","year":"2023","unstructured":"Barnes EL, Long MD, Raffals L, Isaacs K, Stidham RW, Herfarth HH, et al. Development of the endoscopic pouch score for assessment of inflammatory conditions of the pouch. Clin Gastroenterol Hepatol. 2023;21(6):1663\u2013e63.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"994_CR69","doi-asserted-by":"publisher","first-page":"i416","DOI":"10.1093\/ecco-jcc\/jjac190.0398","volume":"17","author":"R Sedano","year":"2023","unstructured":"Sedano R, Ma C, Hogan M, Silverberg MS, Zou G, D\u2019Haens G, et al. Development and validation of a novel composite index for the assessment of endoscopic and histologic disease activity in pouchitis: the Atlantic pouchitis index. J Crohn\u2019s Colitis. 2023;17:i416\u20137.","journal-title":"J Crohn\u2019s Colitis"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-00994-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-025-00994-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-00994-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:03:44Z","timestamp":1772579024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-025-00994-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1007\/s11894-025-00994-4","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"10 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AJ\u2013 none SH\u2013 none GS\u2013 Advisory fee from Johnson & Johnson","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"40"}}